
Healthcare · BSE
Incorporated in 2014, Trident Lifeline Limited is engaged in the marketing and distribution of pharmaceutical products in domestic and international markets through a third-party distribution network. The company offers a portfolio of 832 products as of May 31, 2022, including antibiotics, antifungals, antimalarials, antidiabetics, dental care products, proton pump inhibitors, antihistamines, antihypertensives, antiparasitics, multivitamins, multiminerals, and NSAIDs. Its core business includes ethical marketing of pharmaceutical formulations internationally under its brand and sourcing approved formulations through contract manufacturers for both domestic and global markets. Trident Lifeline has a presence in India as well as in African, Latin American, and East Asian countries, with registered or under-registration products in Bolivia, Cambodia, Cameroon, Chile, Ghana, Kenya, Myanmar, Nigeria, Peru, Sudan, Tajikistan, Uzbekistan, and Venezuela.
Price Band
₹101
Issue Size
₹35.34 Cr
Lot Size
1200 shares
GMP
+2.0%
Est. Listing
₹103
at current GMP
Subscribed
1.34x
overall
Open
26 Sep 2022
Close
29 Sep 2022
Allotment
4 Oct 2022
Refund
5 Oct 2022
Demat Credit
6 Oct 2022
Listing
10 Oct 2022
Overall Subscription
1.34x
Total Demand
QIB Multiplier
0.00x
Institutions & Funds
NII / HNI
0.00x
High Net-Worth
Retail (RII)
0.00x
Individual Bidders
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| Qualified Institutional (QIB) | 1,749,505 | — | 0.00x |
| Non-Institutional (NII / HNI) | 524,851 | — | 0.00x |
| Retail Individual (RII) | 1,224,653 | — | 0.00x |
| Total | 3,499,009 | 0 | 1.34x |
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| Retail (RII) | 1,021 | 1,368 | 1.34x |
| HNIs (10L +) | 7 | 9 | 1.29x |
| HNIs (2-10L) | 31 | 42 | 1.35x |
| Total Applications | 1,059 | 1,419 | 1.34x |
Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.
Trident Lifeline Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹35.34 Crores. The shares are offered at a price band of ₹101 to ₹101 per equity share on BSE. Currently, grey market participants and retail investors are watching the bidding trend, premium movement, and anchor book demand with keen interest.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 1200 shares (approx. ₹1,21,200 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Link Intime India Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2022-10-06, while un-allotted funds or UPI block mandates will be released on 2022-10-05.
The latest Grey Market Premium (GMP) for Trident Lifeline Limited IPO is ₹2 per equity share. Based on the upper price band of ₹101 to ₹101 per equity share, the estimated listing price is ₹103 (+2.0% expected listing gain).
With a lot size of 1200 shares and current GMP of ₹2, the expected profit per application lot is approx ₹2,400 (+2.0% gain). Minimum application cost is approx ₹1,21,200.
The Trident Lifeline Limited IPO aggregate issue size is ₹35.34 Crores with an equity price band set at ₹101 to ₹101 per equity share. The retail lot size is 1200 shares requiring a minimum capital outlay of approx. ₹1,21,200.
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 1.34x (Retail: 0.00x, QIB: 0.00x, NII: 0.00x). You can track live multiples directly on our dedicated subscription page.
The basis of allotment will be published on the official registrar portal (Link Intime India Private Limited) and the BSE status verification website on or around 2022-10-04. Investors can verify status using PAN card or application number.
Trident Lifeline Limited shares are scheduled to list on BSE on 2022-10-10.